par Peeters, Marc;Price, Tim;Van Laethem, Jean-Luc 
Référence The oncologist, 14, 1, page (29-39)
Publication Publié, 2009-01
Référence The oncologist, 14, 1, page (29-39)
Publication Publié, 2009-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Peeters, Marc; Price, Tim; Van Laethem, Jean-Luc |
| Informations sur la publication: | The oncologist, 14, 1, page (29-39) |
| Statut de publication: | Publié, 2009-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Cetuximab |
| EGFR | |
| MCRC | |
| Monotherapy | |
| Panitumumab | |
| MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
| Antineoplastic Agents -- therapeutic use | |
| Clinical Trials, Phase II as Topic | |
| Clinical Trials, Phase III as Topic | |
| Colorectal Neoplasms -- drug therapy -- enzymology -- pathology | |
| Female | |
| Humans | |
| Male | |
| Neoplasm Metastasis | |
| Randomized Controlled Trials as Topic | |
| Receptor, Epidermal Growth Factor -- antagonists & inhibitors | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1083-7159 |
| info:doi/10.1634/theoncologist.2008-0167 | |
| info:pii/theoncologist.2008-0167 | |
| info:scp/61449162243 | |
| info:pmid/19144681 |
